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Abstract
Background:  The  acute  renal  failure  (ARF)  contributes  to  a  longer  hospital  stay,  morbidity,
mortality  and  use  of  resources  in  critical  patients.
The estimate  of  its  incidence  was  difﬁcult,  mainly  due  to  the  lack  of  a  generally  accepted
deﬁnition.
Objective: To  determine  the  incidence,  risk  factors  and  effects  of  the  ARF  in  critical  patients.
Material and  methods:  Study  of  prospective  cohort.  Patients  hospitalised  in  the  Intensive  Care
Unit (ICU)  were  included.  The  population  was  divided  into  4  groups:  A:  without  ARF;  B:  with
ARF at  ICU  admission;  C:  ARF  developed  at  the  ICU;  and  D:  ARF  at  the  admission,  solved  and
developed  again  at  the  ICU.  Descriptive  and  inferential  statistics  (Student’s  t,  2 and  ANOVA).
Results: Of  360  patients,  50.5%  were  men.  The  mean  age  was  49  years.  From  the  total,  145
(40.3%) did  not  develop  ARF  (group  A).  The  main  comorbidities  were  diabetes  mellitus  and  high
blood pressure.  Patients  with  sepsis,  shock  and  multiple  organ  failure  showed  a  greater  ARF
frequency (p  <  0.001).  The  ARF  incidences  were  30.3%  in  group  B,  20.3%  in  group  C  and  9.2%
in group  D.  The  attributable  mortality  was  11.8%,  16.6%  and  26.1%,  respectively.  There  was  a
higher use  of  resources  in  groups  C  and  D.
Conclusions:  The  ARF  incidence  in  critical  patients  ranges  from  9.2%  to  30.3%.  The  main  risk
factors are  sepsis,  shock  and  MODS.
© 2014  Sociedad  Médica  del  Hospital  General  de  México.  Published  by  Masson  Doyma  México
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Incidencia  de  la  lesión  renal  aguda  en  la  unidad  de  cuidados  intensivos  del  hospital
general  de  México:  factores  de  riesgo  y  morbi-mortalidad  asociada
Resumen
Antecedentes:  La  lesión  renal  aguda  (LRA)  contribuye  a  mayor  estancia  hospitalaria,  morbili-
dad, mortalidad  y  consumo  de  recursos  en  pacientes  críticos.
Estimar  su  incidencia  era  complicado,  principalmente  por  la  falta  de  una  deﬁnición  general-
mente aceptada.
Objetivo:  Determinar  incidencia,  factores  de  riesgo  y  efectos  de  la  LRA  en  pacientes  críticos.
Material  y  métodos: Estudio  de  cohorte  prospectiva.  Se  incluyeron  pacientes  hospitalizados  en
Unidad de  Cuidados  Intensivos  (UCI).  La  población  se  dividió  en  4  grupos:  A.  Sin  LRA;  B.  con
LRA al  ingreso  a  UCI;  C.  LRA  desarrollada  en  UCI;  y,  D.  LRA  al  ingreso,  resuelta  y  nuevamente
desarrollada  en  UCI.  Estadística  descriptiva  e  inferencial  (t  de  Student,  2 y  ANOVA).
Resultados:  De  360  pacientes,  50.5%  fueron  hombres.  La  edad  media  fue  49  an˜os.  Del  total,  145
(40.3%) no  desarrollaron  LRA  (grupo  A).  Las  principales  comorbilidades  fueron  diabetes  mellitus
e hipertensión  arterial.  Los  pacientes  con  sepsis,  choque  y  falla  multiorgánica  presentaron
mayor frecuencia  de  LRA  (p<0.001).  Las  incidencias  de  LRA  fueron  30.3%  en  el  grupo  B,  20.3%
en el  grupo  C  y  9.2%  en  el  grupo  D.  La  mortalidad  atribuible  fue  de  11.8%,  16.6%  y  26.1%,
respectivamente.  Hubo  mayor  consumo  de  recursos  en  los  grupos  C  y  D.
Conclusiones:  La  incidencia  de  LRA  en  pacientes  críticos  oscila  entre  9.2%  y  30.3%.  Los  princi-
pales factores  de  riesgo  son  sepsis,  choque  y  SDOM.
© 2014  Sociedad  Médica  del  Hospital  General  de  México.  Publicado  por  Masson  Doyma  México
S.A. Todos  los  derechos  reservados.
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iIntroduction
Acute  renal  failure  (ARF)  is  a  frequent  problem  which  signif-
icantly  contributes  to  morbidity  and  mortality,  particularly
in  critical  patients.  It  is  characterised  by  the  sudden  loss  of
the  kidney  capacity  to  excrete  waste  products,  concentrate
urine,  preserve  electrolytes  and  keep  the  water  balance.
It  is  particularly  common  in  the  intensive  care  unit  (ICU),
where  it  is  associated  to  a  50--80%  mortality.1--4
In  Mexico,  different  studies  have  reported  differing  inci-
dence  and  mortality  rates  because  there  was  no  accepted
ARF  deﬁnition.5--9
The  aim  of  this  study  is  to  assess  the  incidence,  risk  fac-
tors,  effects  on  the  morbidity,  mortality  and  use  of  resources
in  patients  who  were  admitted  to  the  intensive  care  unit
(ICU)  at  the  university  general  hospital  in  Mexico,  using  the
updated  deﬁnition  of  the  group  Acute  Kidney  Injury  Network
(AKIN).4
Material and methods
In  this  study  of  the  prospective  cohort,  18  year-old  patients
admitted  to  the  ICU  of  the  General  Hospital  in  Mexico  were
included,  from  April  2013  to  October  2014.  Patients  with
chronic  renal  disease  were  excluded.
Demographic  information  (age,  genre),  clinical  data
(urine  output  per  hour  by  kilogram  and  creatinine),  presence
of  comorbidities  (sepsis,  shock,  multiple  organ  dysfunction
syndrome  (MODS))  were  collected.  The  Scale  for  the  Assess-
ment  of  Positive  Symptoms  (SAPS  3  (severity  of  the  disease)),
modiﬁed  Brussels  scale  (organic  failure)  and  Nine  Equiva-
lents  nursing  Manpower  use  Score  (NEMS  (use  of  resources))
y
f
s
(ere  assessed.10--12 The  use  of  resources  (invasive  mechani-
al  ventilation,  continuous  drug  infusions,  blood  derivatives,
ength  of  stay  in  the  ICU  and  hospital  stay)  were
ecorded.
The  ARF  was  deﬁned  as  the  stage  1  of  the  AKIN  clas-
iﬁcation,  creatinine  increase  >0.3  mg/dL  or  1.5--2  times
ncrease  in  basal  value,  urine  output  <0.5  mL/Kg/h  per  six
ours 4.
Sepsis  was  deﬁned  as  the  presence  of  infection  together
ith  systemic  manifestations  (temperature  >38.3 ◦C  or
36 ◦C,  heart  rate  >90  heartbeats  per  minute,  tachypnoea,
eukocytes  >12,000/L  or  <4000/L,  systolic  blood  pres-
ure  <90  Torr).  Severe  sepsis  such  as  low  blood  perfusion
nduced  by  sepsis  or  organic  dysfunction  (hyperlactataemia,
aO2/FiO2  <300,  urine  output  <0.5  mL/Kg/h,  creatinine
2  mg/dL,  bilirrubine  >2  mg/dL,  platelets  <100,000/L).13
Multiple  organ  dysfunction  syndrome  (MODS)  was  deﬁned
s  the  progressive  dysfunction  of  two  or  more  physiological
ystems  considered  as  the  sum  of  6  or  more  points  in  the
odiﬁed  Brussels  scale.11
Patients  were  divided  into  four  groups.  Group  A,  patients
ho  did  not  show  ARF;  group  B,  patients  who  already  had
RF  at  the  admission  to  the  ICU;  group  C,  patients  who
eveloped  ARF  during  their  stay  at  the  ICU;  and  group  D,
atients  who  were  admitted  with  ARF  which  was  resolved
uring  their  stay  and  developed  again  in  the  same  stay  at
he  ICU.  Descriptive  statistics:  Frequencies,  proportions,
rithmetical  means,  standard  deviations  and  cumulative
ncidence  of  ARF.  Inferential  statistics:  2-way  ANOVA  (anal-
sis  of  variance)  test  for  the  dimensional  variables  and  2
or  non-parametric  variables,  considering  a  p  value  <0.05
igniﬁcant.  The  statistical  package  used  was  the  SPSS  v.  13
SPSS®, Chicago,  IL,  USA).
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Table  1  Comparison  among  groups.
VARIABLE  GROUP  A  GROUP  B  GROUP  C  GROUP  D  p
Patients,  %  145  (40.3)  109  (30.3)  73  (20.3)  33  (9.2)  0.648
Men, %  74  (51.0)  54  (49.5)  40  (54.8)  14  (42.4)  <0.001
Age, years  43.7  ±  17.0  50.8  ±  16.3  49.8  ±  17.0  54.4  ±  15.7  <0.001
Surgical patients,  %  70  (48.6)  32  (29.4)  27  (37.0)  5  (15.2)  <0.001
SAPS 3  classiﬁcation,  scores  45.4  ±  15.7  57.7  ±  16.7  53.8  ±  14.8  59.9  ±  15.2  <0.001
Predicted mortality,  %  24.0  44.2  35.5  46.6  <0.001
Observed mortality,  %  18.6  56.0  52.1  72.7  <0.001
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aAttributable  mortality,  % NA  1
esults
uring  the  study  period,  400  patients  were  included  in  the
ohort;  31  of  them  were  excluded  because  they  had  chronic
enal  disease  and  9  because  they  did  not  have  full  informa-
ion.  360  cases  remained  for  the  analysis.
Of  the  360  patients,  182  (50.5%)  were  men.  The  mean
ge  was  49  years.  The  information  by  groups  is  found  in
able  1.  Patients  with  ARF  during  admission  to  the  ICU,
olved  and  developed  it  again  during  their  stay  in  ICU,  were
he  oldest  patients,  generally  came  from  medical  areas  and
howed  a  higher  severity  of  the  disease  (p  <  0.001,  for  all  the
ariables).  The  progressive  gradient  of  attributable  mortal-
ty  between  groups  from  11.8%  in  group  B  to  26.1%  in  group
 stands  out.
The  ARF  incidence  varied  according  to  the  group  and  cri-
erion  used.  The  group  incidences  were  30.3%  for  group  B,
0.3%  for  group  C  and  9.2%  for  group  D.  Therefore,  the  high-
st  incidences  were  found  when  the  uresis  criterion  was
sed.  The  lowest  incidences  were  obtained  when  uresis  and
reatinine  criteria  were  required  (Table  2).
The  main  comorbidities  were  diabetes  mellitus  type  2
nd  hypertension,  with  no  signiﬁcant  difference  among
roups.  However,  a  hypertension  gradient  was  found  among
roups.  There  were  no  documented  differences  among
roups  regarding  the  presence  and  origin  of  infections
Table  3).  However,  the  presence  of  sepsis,  shock,  MODS
nd  the  use  of  vasopressors  at  admission  were  frequently
ound  from  groups  A  to  D  (p  >  0.001),  these  conditions  hav-
ng  a  deleterious  effect  of  on  renal  function.  The  relative
isks  of  the  presence  of  sepsis,  shock  and  MODS  on  admis-
ion  to  the  ICU  were  associated  with  the  ARF  development
uring  the  stay  in  the  ICU,  and  were  the  following:  1.176
CI  95%  1.051--1.316),  1.441  (CI  95%  1.159--17.91)  and  1.376
CI  95%  1.023--1.851),  respectively.  The  nephrotoxic  agents
ere  more  used  in  groups  C  and  D  (p  <  0.001),  whereas  the
asoactives  were  more  used  in  groups  B  and  D.  Similarly,
epsis,  shock  and  MODS  developed  during  the  stay  in  the  ICU
ere  commonly  related  to  the  ARF  from  group  A  to  group  D.
c
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Table  2  Used  criteria  to  deﬁne  ARF  by  groups.
VARIABLE  GROUP  A  GROUP  B  
Uresis  criterion,  % NA  68  (62.4)  
Creatinine criterion,  %  NA  44  (40.4)  
Both criteria,  %  NA  30  (27.5)  16.6  26.1  <0.001
 higher  number  of  days  of  MODS  were  also  documented  as
t  progressed  from  group  A  to  group  D  (p  <  0.001)  (Table  4).
In  addition,  patients  required  a  higher  number  of  vital
upport  elements  if  they  had  ARF  on  admission  and  then
eveloped  it  in  the  ICU,  or  in  case  both  events  took  place
Table  5)  (p  <  0.001,  for  all  the  cases).  This  is  also  reﬂected  in
he  length  of  stay  in  the  ICU  and  the  hospital,  and  the  use  of
esources  assessed  by  the  NEMS  score  (p  <  0.001)  (Table  6).
iscussion
his  is  the  ﬁrst  ARF  study  of  Mexican  critical  patients  that
resents  its  incidence  using  the  AKIN  group’s  deﬁnition.  It  is
lso  the  ﬁrst  one  to  study  the  risk  factors,  medical  conse-
uences  and  use  of  resources  in  this  population.
The  ARF  incidences  vary  according  to  whether  it  is
resent  on  admission  to  the  ICU  and  then  is  resolved,  if  it
s  developed  during  the  stay  in  the  ICU  or  it  is  present  on
dmission  to  the  ICU,  or  it  is  resolved  and  then  develops
gain  and  this  is  correlated  to  morbidity,  mortality  and  the
se  of  resources.  Therefore,  when  performing  studies  of  this
ondition,  the  time  of  presentation  should  be  considered.
hus,  in  this  study,  the  ARF  was  more  common  on  admis-
ion  to  the  ICU,  then  the  one  developed  during  the  stay  and,
nally,  the  one  present  at  the  admission,  which  was  resolved
nd  then  appeared  again.  This  has  already  been  mentioned
y  our  group.9
The  incidences  reported  in  the  three  groups  are  found
ithin  intervals  reported  in  literature  which  generally
onsider  only  the  ARF  developed  in  the  ICU,  reporting
0.1--69.5%  rates,  according  to  the  scale  used  and  stage.14--17
As  Salgado  et  al.  have  reported,  the  uresis  criterion  is
ore  sensitive  than  the  creatinine  criterion  to  deﬁne  ARF,
s  found  in  this  study.14
Similarly,  Levi  et  al.  reported  that  patients  from  medi-
al  areas  showed  more  ARF  cases  than  surgical  patients.  In
ddition,  older  patients  were  found  in  groups  B  and  D,  those
ho  had  ARF  on  admission  to  the  ICU,  regardless  of  whether
t  was  resolved  and  developed  again.16
GROUP  C  GROUP  D  p
38  (52.1)  17  (51.5)  <0.001
26  (35.6)  13  (39.4)
9  (27.3)  3  (9.1)
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Table  3  ARF  risk  factors.
VARIABLE  GROUP  A  GROUP  B  GROUP  C  GROUP  D  p
Hypertension,  %  18  (12.4)  24  (22.0)  15  (20.5)  10  (30.3)  0.053
Diabetes mellitus,  %  21  (14.5)  24  (22.0)  18  (24.7)  7  (21.2)  0.254
Hospital-acquired  infection,  %  15  (10.3)  12  (11.0)  8  (11.0)  5  (15.2)  0.888
Respiratory  infection,  %  69  (47.6)  56  (51.4)  44  (60.3)  21  (63.6)  0.182
Sepsis at  the  admission,  %  92  (63.4)  90  (82.6)  59  (80.8)  29  (87.9)  <0.001
Shock at  the  admission,  %  45  (31.0)  59  (54.1)  42  (57.5)  19  (57.6)  <0.001
MODS at  the  admission,  %  24  (16.6)  52  (47.7)  27  (37.0)  16  (48.5)  <0.001
Vasoactive before  ICU,  %  20  (13.8)  35  (32.1)  16  (21.9)  9  (27.3)  0.006
Nephrotoxics,  number 0.9  ±  1.0 1.3  ±  0.9 1.4  ±  1.0 1.6  ±  1.2  <0.001
Table  4  Comorbidities  developed  during  the  stay  in  the  ICU.
VARIABLE  GROUP  A  GROUP  B  GROUP  C  GROUP  D  p
Sepsis  during  stay,  %  25  (17.2)  28  (25.7)  16  (21.9)  22  (66.7)  <0.001
Shock during  stay,  %  29  (20.0)  24  (22.0)  21  (28.8)  22  (66.7)  <0.001
MODS during  stay,  %  16  (11.0)  21  (19.3)  26  (35.6)  17  (51.5)  <0.001
MODS, days  1.4  ±  3.8  2.7  ±  3.6  3.2  ±  4.8  7.3  ±  7.6  <0.001
Table  5  Use  of  resources.
VARIABLE  GROUP  A  GROUP  B  GROUP  C  GROUP  D  p
Mechanical  ventilation,  days  10.3  ±  13.1  7.5  ±  10.8  8.6  ±  8.7  14.6  ±  13.3  <0.001
Dialysis, %  NA  4  (3.7)  0  (0.0)  1  (3.0)  NS
Antibiotics,  number  1.9  ±  2.0  2.3  ±  1.9  2.8  ±  2.2  4.5  ±  2.8  <0.001
Drug infusions,  number  1.8  ±  2.0  3.1  ±  2.5  3.7  ±  2.2  5.1  ±  2.8  <0.001
Blood components,  number  0.2  ±  0.5  0.3  ±  0.6  0.3  ±  0.5  0.7  ±  0.9  <0.001
Stay in  the  ICU,  days  7.2  ±  9.5  7.5  ±  10.3  9.8  ±  8.4  18.3  ±  13.9  <0.001
Length of  hospital  stay,  days  27.2  ±  20.6  17.3  ±15.3  20.9  ±  12.2  29.8  ±  26.8  <0.001
NEMS, points  172.5  ±  281.4  199.1  ±  289.1  272.1  ±  266.4  510.8  ±  404.9  <0.001
Table  6  NEMS  scale.
ITEM  POINTS
1  Basic  monitoring:  hourly  vital  signs,  regular  register  and  estimate  of  liquid  balance  9
2 Intravenous  medications:  bolus  or  continuous  infusion,  vasoactive  drugs  are  not  included.  6
3 Mechanical  ventilatory  support:  any  form  of  mechanical/assisted  ventilation,  with  or  without  positive  and
expiratory pressure  (PEEP),  with  or  without  muscle  relaxants
12
4 Supplementary  ventilatory  care:  spontaneous  respiration  by  endotracheal  cannula;  any  form  of
supplementary  oxygen,  with  the  exception  of  the  item  three  application
3
5 Unique  vasoactive  medication:  any  vasoactive  drug  7
6 Multiple  vasoactive  medications:  more  than  one  vasoactive  drug,  regardless  of  the  type  and  dose  12
7 Dialysis  techniques:  all  6
8 Speciﬁc  interventions  in  the  ICU:  such  as  endotracheal  intubation,  pacemaker  installation,  cardioversion,
endoscopy,  emergency  surgery  in  the  last  24  hours,  gastric  lavage;  routine  procedures  such  as  X-rays,
echocardiogram,  electrocardiogram,  placement  of  venous  or  arterial  catheters  are  not  included
5
9 Speciﬁc  interventions  outside  the  ICU:  such  as  a  surgical  intervention  or  diagnostic  procedure:  the
intervention/procedure  is  related  to  the  severity  of  the  disease  and  produces  an  extra  demand  on  the
6workload of  the  ICU  staff
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Regarding  the  risk  factors,  the  same  factors  as  those  in
nternational  literature  were  found.16,18 Sepsis  and  shock
ontinue  being  the  main  risk  factors  for  ARF  development.
t  the  same  time,  the  management  of  these  clinical  condi-
ions  requires  a  greater  use  of  vasoactives  and  drugs  that
urn  to  be  nephrotoxic,  favouring  the  persistence  of  renal
amage,  as  previously  reported.9
ARF  development  is  an  independent  mortality  predictor,
ncreasing  from  18.6%  without  ARF  to  72.7%  when  two  or
ore  ARF  events  occur  on  admission  and  then  during  the
tay  in  the  ICU.  However,  mortality  was  lower  than  reported
n  the  literature;  it  reached  up  to  50%  in  some  series.14,19 In
his  way,  the  mortality  attributable  to  ARF  on  admission  was
1.8%,  but  increased  to  26.1%  when  there  were  two  or  more
RF  events  from  admission  to  the  ICU.
The  mechanism  by  which  the  ARF  contributes  to  the
ncrease  in  mortality  is  not  completely  understood,  but  the
olume  overload,  coagulation  anomalies  and  a  greater  inci-
ence  of  sepsis  and  multiple  organ  failure  play  an  important
ole.20--25
The  use  of  resources  evidently  increases  when  a  patient
evelops  ARF.9 In  the  present  study,  greater  use  of  mechan-
cal  ventilatory  support,  use  of  drug  infusions,  blood
omponents  and  antibiotics  was  documented,  which  led  to  a
onger  stay  in  the  ICU  and  the  hospital.  The  measurement  of
he  use  of  resources  through  the  NEMS  scale  showed  an  out-
ut  greater  than  double  in  the  presence  of  ARF.  The  NEMS
cale  is  equivalent  to  the  Therapeutic  Intervention  Score
ystem  (TISS)  and  its  usefulness  is  to  classify  patients  into  4
lasses  to  assign  nurses  to:  Class  I  <10  points,  patients  who  do
ot  need  UTI;  Class  II  10--19  points,  1:2  nurse--patient  rela-
ion;  Class  III  20--39  points,  1:1  nurse--patient  relation;  and
lass  IV  ≥40  points,  2:1  relation,  two  nurses  per  patient.26
Study  limitations.  The  nature  of  a  unique  centre  limits
eneralisation,  and  the  design  of  a  relatively  small  cohort
oes  not  allow  the  assessment  of  other  contributory  factors
f  prognostic  importance.
However,  the  present  study  characterises  the  incidence,
isk  factors  and  impact  on  the  ARF  regarding  health,  life
nd  use  of  resources,  using  the  most  recent  standardised
eﬁnition  which  simultaneously  uses  the  serum  creatinine
nd  urinary  output  criteria.
unding
one.
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